SEC Form 15-12B filed by PPD, Inc.
$PPD
Biotechnology: Commercial Physical & Biological Resarch
Health Care
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
|
|
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
|
Commission File Number
|
001-39212
|
|
PPD, INC.
|
|
|
(Exact name of registrant as specified in its charter)
|
|
|
929 North Front Street
Wilmington, North Carolina 28401
(910) 251-0081
|
|
|
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
|
|
|
Common Stock, par value $0.01 per share
|
|
|
(Title of each class of securities covered by this Form)
|
|
|
None
|
|
|
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
|
|
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
☒ |
|
Rule 12g-4(a)(2)
|
☐ |
|
Rule 12h-3(b)(1)(i)
|
☒ |
|
Rule 12h-3(b)(1)(ii)
|
☐ |
|
Rule 15d-6
|
☐ |
Approximate number of holders of record as of the certification or notice date: One (1)
Pursuant to the requirements of the Securities Exchange Act of 1934, PPD, Inc. has caused this
certification/notice to be signed on its behalf by the undersigned duly authorized person.
| PPD, INC. | ||||
|
Date: December 20, 2021
|
By:
|
/s/ Julia James |
||
| Name: | Julia James | |||
| Title: | Executive Vice President, General Counsel and Secretary | |||